XRHealth Buys Virtual Addiction Care Provider PursueCare
Adults with substance use disorder may gain access to telehealth treatment paired with FDA-cleared digital therapy.
Updated on Nov. 10, 2026 in Substance Abuse
Virtual behavioral health provider XRHealth has acquired PursueCare, an addiction treatment company that treats alcohol, opioid, cannabis, kratom, and 7-OH use disorders. The deal also includes PursueCare's RESET and RESET-O prescription digital therapeutics, which are FDA-authorized for use alongside other treatment for adults with substance use disorder.
Why it matters
Addiction treatment faces severe clinician shortages, provider deserts in rural areas, stigma, and financial barriers, and the acquisition is aimed at reaching more people through virtual care. With 44.6 million Americans aged 12 or older reporting a substance use disorder in 2025, the consolidation of telehealth, medication-assisted treatment, and digital therapeutics is a notable shift in how care may be delivered nationwide.
The prevalence and treatment figures come from 2025 national survey data on substance use among Americans aged 12 and older. The RESET program is indicated for a 12-week course to increase abstinence and program retention in adult outpatient populations with substance use disorder.
The players
XRHealth
A virtual reality and telehealth company that delivers digital behavioral health care, including immersive group therapy.
PursueCare
A virtual behavioral health provider specializing in addiction treatment for alcohol, opioids, cannabis, kratom, and 7-OH, and the developer of multidisciplinary telehealth clinics.
The details
PursueCare uses medication-assisted treatment, such as transmucosal buprenorphine for opioid use disorder, paired with telehealth clinics. RESET and RESET-O are FDA-cleared software therapies, originally developed by Pear Therapeutics, that patients use asynchronously between live clinical visits. RESET-O provides an 84-day cognitive behavioral therapy regimen alongside buprenorphine, while RESET runs over 12 weeks. XRHealth plans to fold PursueCare's clinical caseload into its virtual reality platform, where avatar-based group therapy lets patients join peer recovery circles with a degree of anonymity.
Timeline
November 9, 2026: XRHealth announced the acquisition of PursueCare.
Health Landscape
The deal places FDA-cleared digital therapeutics, which have been developed as software-based add-ons to medication treatment, inside a broader shift toward virtual addiction care. It reflects an effort to close the gap in which most Americans with a substance use disorder receive no treatment at all.
If you or someone you know is dealing with alcohol, opioid, cannabis, or other substance use, telehealth-based treatment may be an option to ask a clinician about. Anyone currently on buprenorphine or considering medication-assisted treatment should discuss with their physician whether a combined telehealth and digital therapy approach fits their care.
The takeaway
Most Americans who need substance use treatment do not receive it, so expanding access through telehealth and digital tools is a meaningful development to watch. If you're seeking help, ask a primary care provider or addiction specialist whether virtual treatment options are available in your area.
Further reading
Explore more reporting in our Substance Abuse section for context on treatment access and recovery options.
Source note: This article includes information reported by Hitconsultant.
